![Mya Thomae](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mya Thomae
Consultant / Advisor chez
Delfi Diagnostics, Inc.
Profil
Mya Thomae is the founder of Myraqa, Inc. which was founded in 2008.
She held the title of Chief Executive Officer from 2008 to 2014.
Currently, she is a Regulatory Advisor at Delfi Diagnostics, Inc. since 2019.
In the past, she worked as a Director at Transgenomic, Inc. from 2015 to 2017, Manager-Regulatory Affairs at Chiron Corp.
from 1996 to 1997, and Manager-Regulatory Affairs at Epitope, Inc. from 1992 to 1995.
She also served as Vice President-Regulatory Affairs at Illumina, Inc. from 2014 to 2017.
Ms. Thomae has also founded HX Diagnostics, Inc. and served as Vice President-Regulatory & Clinical Affairs.
She was also an Advisor at Illumina Accelerator.
Ms. Thomae received her undergraduate degree from the University of Wisconsin.
Postes actifs de Mya Thomae
| Sociétés | Poste | Début |
|---|---|---|
Delfi Diagnostics, Inc.
 Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Consultant / Advisor | 01/10/2019 |
Anciens postes connus de Mya Thomae
| Sociétés | Poste | Fin |
|---|---|---|
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Directeur/Membre du Conseil | 28/06/2017 |
| ILLUMINA, INC. | Conseiller Juridique Général | 01/06/2017 |
Myraqa, Inc.
 Myraqa, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services | Directeur Général | 01/07/2014 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Conseiller Juridique Général | 01/01/1997 |
Epitope, Inc.
 Epitope, Inc. Medical SpecialtiesHealth Technology Develops diagnostic tests and related products | Conseiller Juridique Général | 01/01/1995 |
Formation de Mya Thomae
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Epitope, Inc.
Epitope, Inc. Medical SpecialtiesHealth Technology Develops diagnostic tests and related products | Health Technology |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Health Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HX Diagnostics, Inc.
 HX Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services for infectious diseases | Health Services |
Myraqa, Inc.
Myraqa, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic services | Health Services |
Illumina Accelerator
 Illumina Accelerator Investment ManagersFinance Illumina Accelerator invests in companies located across the globe. The firm targets companies operating in the fields of genomics, including novel therapeutics, agriculture, synthetic biology, software and direct-to-consumer applications. The firm provides financing for seed and early-stage capital requirements with an investment size up to USD 0.2 million. | Finance |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Health Technology |
